Exelon® 9,5mg/24 Stunden transdermales Pflaster
Novartis Pharma GmbH
| Packungen | ZuZa | VS | FB | AVP | Diff. | PZN |
| Exelon 9,5mg/24 Stunden 30 Pflaster, transderm. N1 |  |
|
|
|||
| Exelon 9,5mg/24 Stunden 60 Pflaster, transderm. N2 | |
|
|
|||
| Exelon 9,5mg/24 Stunden 90 Pflaster, transderm. N3 | |
|
|
Wirkstoffe
Weitere Bestandteile
Poly(ethylenterephthalat), all-rac-α-Tocopherol, Poly(butylmethacrylat, methylmethacrylat), Poly[(2-ethylhexyl)acrylat-co-methylacrylat-co-acrylsäure-co-(2,3-epoxypropyl)methacrylat], Silikonöl, Dimethicon, Fluoropolymerbeschichteter Polyesterfilm
ATC-Code
N06DA03 Rivastigmin
Identa